Seymour Perry

3.8k total citations
115 papers, 2.9k citations indexed

About

Seymour Perry is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, Seymour Perry has authored 115 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 27 papers in Oncology and 21 papers in Hematology. Recurrent topics in Seymour Perry's work include Health Systems, Economic Evaluations, Quality of Life (20 papers), Neutropenia and Cancer Infections (16 papers) and Hematological disorders and diagnostics (10 papers). Seymour Perry is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (20 papers), Neutropenia and Cancer Infections (16 papers) and Hematological disorders and diagnostics (10 papers). Seymour Perry collaborates with scholars based in United States, Malaysia and India. Seymour Perry's co-authors include Edward S. Henderson, Robert G. Graw, Jacqueline Whang‐Peng, Robert C. Gallo, John C. Marsh, Geoffrey P. Herzig, Robert Eisel, Dean Buckner, T. R. Breitman and Ronald D. Barr and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Seymour Perry

113 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Seymour Perry United States 30 976 677 624 399 370 115 2.9k
Anne I. Goldman United States 36 1.2k 1.3× 1.9k 2.8× 676 1.1× 326 0.8× 671 1.8× 73 5.1k
M. Schneider France 38 2.8k 2.9× 1.2k 1.8× 1.0k 1.6× 336 0.8× 513 1.4× 108 5.8k
Roy S. Weiner United States 27 798 0.8× 1.1k 1.6× 507 0.8× 113 0.3× 460 1.2× 91 2.9k
M. Robert Cooper United States 37 3.4k 3.5× 1.0k 1.5× 908 1.5× 633 1.6× 629 1.7× 138 7.3k
J S Lilleyman United Kingdom 35 469 0.5× 1.6k 2.3× 641 1.0× 423 1.1× 306 0.8× 135 4.8k
Andrew T. Huang United States 38 1.7k 1.7× 353 0.5× 1.3k 2.1× 485 1.2× 456 1.2× 92 5.3k
James F. Bishop Australia 29 1.6k 1.6× 465 0.7× 537 0.9× 126 0.3× 84 0.2× 118 3.0k
M. Staquet France 23 3.9k 4.0× 549 0.8× 1.2k 2.0× 234 0.6× 570 1.5× 85 8.5k
William P. Vaughan United States 30 868 0.9× 1.0k 1.5× 364 0.6× 160 0.4× 165 0.4× 89 2.8k
Hong Zhou China 38 723 0.7× 825 1.2× 1.3k 2.1× 150 0.4× 322 0.9× 112 6.4k

Countries citing papers authored by Seymour Perry

Since Specialization
Citations

This map shows the geographic impact of Seymour Perry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Seymour Perry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Seymour Perry more than expected).

Fields of papers citing papers by Seymour Perry

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Seymour Perry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Seymour Perry. The network helps show where Seymour Perry may publish in the future.

Co-authorship network of co-authors of Seymour Perry

This figure shows the co-authorship network connecting the top 25 collaborators of Seymour Perry. A scholar is included among the top collaborators of Seymour Perry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Seymour Perry. Seymour Perry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Perry, Seymour. (1999). Medical Innovation and the Critical Role of Health Technology Assessment. JAMA. 282(19). 1869–1869. 22 indexed citations
2.
Perry, Seymour. (1999). REPORT FROM THE ALBERTA HERITAGE FOUNDATION FOR MEDICAL RESEARCH. International Journal of Technology Assessment in Health Care. 15(1). 265–266. 1 indexed citations
3.
Perry, Seymour, et al.. (1997). The Status of Health Technology Assessment Worldwide: Results of an International Survey. International Journal of Technology Assessment in Health Care. 13(1). 81–98. 36 indexed citations
4.
Perry, Seymour. (1997). Report from the Swedish Council on Technology Assessment in Health Care (SBU). International Journal of Technology Assessment in Health Care. 13(4). 647–649. 16 indexed citations
5.
Perry, Seymour & Mae Thamer. (1997). Health technology assessment: Decentralized and fragmented in the US compared to other countries. Health Policy. 40(3). 177–198. 19 indexed citations
6.
Thamer, Mae, et al.. (1997). Medical and Surgical Supply Costs: Case Study of a Costly Low-Cost Technology. International Journal of Technology Assessment in Health Care. 13(4). 526–536. 6 indexed citations
7.
Pasternak, Sylvia, Valerie A. White, R. D. Gascoyne, et al.. (1996). Monoclonal origin of localised orbital amyloidosis detected by molecular analysis.. British Journal of Ophthalmology. 80(11). 1013–1017. 29 indexed citations
8.
Perry, Seymour. (1994). Report from The Swedish Council on Technology Assessment in Health Care (SBU). International Journal of Technology Assessment in Health Care. 10(4). 714–715. 25 indexed citations
9.
Perry, Seymour, et al.. (1992). The Technology Assessment and Practice Guidelines Forum: A Modified Group Judgment Method. International Journal of Technology Assessment in Health Care. 8(2). 289–300. 10 indexed citations
10.
Perry, Seymour, et al.. (1990). The Appropriate Use of High-Cost, High-Risk Technologies: The Case of Total Parenteral Nutrition. QRB - Quality Review Bulletin. 16(6). 214–217. 13 indexed citations
11.
Perry, Seymour. (1988). Consensus Development: An Historical Note. International Journal of Technology Assessment in Health Care. 4(4). 481–484. 6 indexed citations
12.
Perry, Seymour. (1982). The Brief Life of the National Center for Health Care Technology. New England Journal of Medicine. 307(17). 1095–1100. 38 indexed citations
13.
Young, Robert C., Vincent T. DeVita, & Seymour Perry. (1969). The thymidine-14C and -3H double-labeling technic in the study of the cell cycle of L1210 leukemia ascites tumor in vivo.. PubMed. 29(8). 1581–4. 26 indexed citations
14.
Perry, Seymour. (1969). Reduction of toxicity in cancer chemotherapy.. PubMed. 29(12). 2319–25. 11 indexed citations
15.
Gallo, Robert C. & Seymour Perry. (1969). The enzymatic mechanisms for deoxythymidine synthesis in human leukocytes. Journal of Clinical Investigation. 48(1). 105–116. 43 indexed citations
16.
Perry, Seymour. (1968). Physiology of the Granulocyte—Part 2. JAMA. 203(12). 1025–1025. 5 indexed citations
17.
Levitan, Alexander A. & Seymour Perry. (1967). Infectious Complications of Chemotherapy in a Protected Environment. New England Journal of Medicine. 276(16). 881–886. 29 indexed citations
18.
Cooper, Richard A., Seymour Perry, & T. R. Breitman. (1966). Pyrimidine metabolism in human leukocytes. II. Metabolism of the thymine nucleotide pools in normal and leukemic leukocytes.. PubMed. 26(11). 2276–81. 14 indexed citations
19.
Breitman, T. R., Seymour Perry, & Richard A. Cooper. (1966). Pyrimidine metabolism in human leukocytes. 3. The utilization of thymine for DNA-thymine synthesis by leukemic leukocytes.. PubMed. 26(11). 2282–5. 14 indexed citations
20.
Moxley, John H., Seymour Perry, George H. Weiss, & Marvin Zelen. (1965). Return of Leucocytes to the Bone Marrow in Chronic Myelogenous Leukaemia. Nature. 208(5017). 1281–1282. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026